Entrada Therapeutics, Inc. (TRDA) Social Stream
Entrada Therapeutics Inc (TRDA) Price Targets From Analysts
Use the tables below to see what analysts covering Entrada Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| NA | 2 | $NA | $NA | $NA | $9.69 | NA% |
TRDA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Entrada Therapeutics Inc's number of analysts covering the stock is higher than 4.69% of Healthcare stocks.
- In the context of stocks in the small market cap category, Entrada Therapeutics Inc's variance in analysts' estimates is lower than almost 100% of them.
- Entrada Therapeutics Inc's average analyst price target is greater than just about none of of stocks in the small market cap category.
- TRDA has a greater upside potential (average analyst target price relative to current price) than just about none of of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Entrada Therapeutics Inc are TNXP, TNGX, and THTX.
Is TRDA a Buy, Hold or Sell? See the POWR Ratings now!